Management of Late Onset Neonatal Sepsis

Initial Empiric Antibiotic Regimen

The American Academy of Pediatrics recommends initiating ampicillin plus gentamicin immediately after obtaining blood cultures for late-onset neonatal sepsis (>72 hours of life) to provide optimal pathogen coverage while minimizing antimicrobial resistance and mortality 1
The World Health Organization recommends amikacin plus cloxacillin (or vancomycin if MRSA is suspected) as first-line therapy for infants with nosocomial risk factors (central venous catheter, prolonged NICU stay, or hospital-acquired infection) 2

Community-acquired late-onset sepsis (days 4-28 of life, no prolonged hospitalization) is associated with pathogens such as Group B Streptococcus, E. coli, and Listeria monocytogenes 1
Nosocomial/hospital-acquired sepsis is associated with pathogens such as coagulase-negative staphylococci, Staphylococcus aureus (including MRSA), resistant gram-negative bacteria, and enterococci 3, 2

Ampicillin plus gentamicin provides coverage against Group B Streptococcus, Enterobacteriaceae (especially E. coli), and Listeria monocytogenes for community-acquired late-onset sepsis 1
Amikacin plus cloxacillin is the WHO-designated primary regimen for nosocomial/hospital-acquired sepsis, providing coverage against resistant staphylococci and gram-negative bacteria 2
Vancomycin plus ceftazidime is recommended when methicillin-resistant organisms are suspected, particularly with central venous catheters or prolonged NICU stays 3, 2

Initiate antibiotics within 1 hour for septic shock, within 3 hours for sepsis without shock 2
Obtain blood cultures before antibiotic administration, but never delay treatment waiting for results 1, 2

If cultures negative and clinical improvement evident at 48-72 hours, discontinue antibiotics to avoid unnecessary exposure 3, 2
If no clinical improvement after 48-72 hours on ampicillin plus gentamicin, immediately escalate to amikacin plus cloxacillin (or vancomycin if MRSA suspected) per WHO recommendations 3
If gram-negative sepsis strongly suspected, add cefotaxime to the regimen 1, 3

Infants with central venous catheters should use vancomycin instead of cloxacillin due to high risk of coagulase-negative staphylococci and MRSA 3
Delaying antibiotic initiation while awaiting culture results increases mortality risk 1
Ignoring local antibiograms can lead to inappropriate empiric selection, as resistance patterns vary significantly between institutions 3, 2

Amikacin demonstrates better sensitivity than gentamicin in many nosocomial settings 2

Once culture results available, de-escalate to the narrowest effective spectrum 2

Initiate intravenous ampicillin together with gentamicin immediately after obtaining blood cultures in neonates with suspected pneumonia and possible sepsis, to provide prompt coverage against the most common pathogens. 4

Use ampicillin at 150–200 mg/kg/day administered intravenously every 6–8 hours combined with gentamicin at 3–7.5 mg/kg/day intravenously; this regimen reliably covers Group B Streptococcus, Escherichia coli, Listeria monocytogenes, and other Enterobacteriaceae implicated in neonatal pneumonia and sepsis. 5

If blood cultures remain negative and the infant shows clinical improvement within 48–72 hours, discontinue the empiric antibiotics to avoid unnecessary drug exposure and to limit the development of antimicrobial resistance. 4